GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Pro Medicus Ltd (FRA:PMC) » Definitions » Deferred Tax

Pro Medicus (FRA:PMC) Deferred Tax : €0.00 Mil (TTM As of Dec. 2023)


View and export this data going back to 2017. Start your Free Trial

What is Pro Medicus Deferred Tax?

Change In Deferred Tax represents future tax liability or asset, resulting from temporary differences between book (accounting) value of assets and liabilities, and their tax value. This arises due to differences between financial accounting for shareholders and tax accounting.

Pro Medicus's change in deferred tax for the six months ended in Dec. 2023 was €0.00 Mil. Its change in deferred tax for the trailing twelve months (TTM) ended in Dec. 2023 was €0.00 Mil.

Pro Medicus Deferred Tax Historical Data

The historical data trend for Pro Medicus's Deferred Tax can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Pro Medicus Deferred Tax Chart

Pro Medicus Annual Data
Trend Jun14 Jun15 Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23
Deferred Tax
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Pro Medicus Semi-Annual Data
Jun14 Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
Deferred Tax Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Pro Medicus Deferred Tax Calculation

Change In Deferred Tax represents future tax liability or asset, resulting from temporary differences between book (accounting) value of assets and liabilities, and their tax value. This arises due to differences between financial accounting for shareholders and tax accounting.

Deferred Tax for the trailing twelve months (TTM) ended in Dec. 2023 adds up the semi-annually data reported by the company within the most recent 12 months, which was €0.00 Mil.


* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Pro Medicus Deferred Tax Related Terms

Thank you for viewing the detailed overview of Pro Medicus's Deferred Tax provided by GuruFocus.com. Please click on the following links to see related term pages.

Pro Medicus (FRA:PMC) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Pro Medicus Ltd (FRA:PMC) » Definitions » Deferred Tax
Comparable Companies
ASX:VHT ASX:MDR ASX:ONE ASX:CGS ASX:M7T ASX:ALC ASX:BMT ASX:PCK ASX:RHT ASX:EMD GEHC VEEV SOLV HQY TSE:2413 RCM DOCS TXG CERT GDRX
Traded in Other Exchanges
PMCUF:USA PME:Australia
Address
450 Swan Street, Richmond, Melbourne, VIC, AUS, 3121
Website
https://www.promed.com.au
Pro Medicus is a healthcare IT company specializing in radiology imaging software. Its main product, Visage 7, is a clinical desktop application that radiologists use to view, enhance, and manipulate images from any device and make a diagnosis. Its main customers are U.S. private academic hospitals. In fiscal 2022, Pro Medicus earned 79% of revenue in North America, 16% from Australia, and the remaining 6% in Europe.

Pro Medicus (FRA:PMC) Headlines

From GuruFocus

PharMerica Corp. Reports Operating Results (10-Q)

By gurufocus 10qk • 11-04-2010

PharMerica Corp. Reports Operating Results (10-Q)

By gurufocus 10qk • 08-05-2010

PharMerica Corp. (PMC) CEO Gregory S Weishar buys 25,000 Shares

By GuruFocus Research GuruFocus Editor • 11-16-2009

Weekly CFO Buys Highlight: PMC, ZBB

By gurujk gurujk • 06-25-2012

PharMerica Corp. (PMC) CEO Gregory S Weishar buys 81,000 Shares

By GuruFocus Research GuruFocus Editor • 08-13-2010